A translational analysis: In vitro hiPSC cardiomyocytes to human phase I analysis for a set of reference compounds with different QT/TdP risk categories

Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Karel Van Ammel, Vijay Urmaliya, Hua Rong Lu, Jutta Rohrbacher, Ivan Kopljar, Hanne Jansen, David J. Gallacher, Ard Teisman
Source: Journal of Pharmacological and Toxicological Methods - Category: Drugs & Pharmacology Source Type: research